Abstract:Subsequently to the publication of this paper, an interested reader drew to the authors' attention that, in Fig. 3 on p. 4973, the data panels shown for the "Osteogenesis" row of data for the GMSC and BMSC experiments appeared to be overlapping, such the data may have been derived from the same original source. After having examined their original data, the authors have realized that the data panel selected for the GMSC "Osteogenesis" experiment was inadvertently chosen incorrectly. The corrected version of Fig. 3 is shown below. Note that this error did not significantly affect the results or the conclusions reported in this paper, and all the authors agree to this Corrigendum. The authors are grateful to the editor of <i>Molecular Medicine Reports</i> for allowing them the opportunity to publish this corrigendum, and apologize to the readership for any inconvenience caused.[Molecular Medicine Reports 18: 4969‑4977, 2018; DOI: 10.3892/mmr.2018.9501].

Corrigendum to “Sox9 augments BMP2-induced chondrogenic differentiation by downregulating Smad7 in mesenchymal stem cells (MSCs)” [Genes & Diseases 4 (2017) 229–239]

Corrigendum to “Characterization of the essential role of bone morphogenetic protein 9 (BMP9) in osteogenic differentiation of mesenchymal stem cells (MSCs) through RNA interference” [ 5(2018):172–184]

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]

Correction: The role of Sox9 in collagen hydrogel-mediated chondrogenic differentiation of adult mesenchymal stem cells (MSCs).

Corrigendum to “development of Methods for Detecting the Fate of Mesenchymal Stem Cells Regulated by Bone Bioactive Materials” [bioact. Mater. 6(3) (2021) 613–626]

Corrigendum: CD317-Positive Immune Stromal Cells in Human “Mesenchymal Stem Cell” Populations

Correction: Corrigendum: Autophagy-associated alpha-arrestin signaling is required for conidiogenous cell development in Magnaporthe oryzae

Corrigendum to “Lipopolysaccharide-induced podocyte injury is regulated by calcineurin/NFAT and TLR4/MyD88/NF-κB signaling pathways through Angiopoietin-like protein 4” [Genes & Diseases 9(2022) 443-455]

Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567]

Correction to: Mesenchymal stem cells in the treatment of severe COVID-19

Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Corrigendum: Role of TGF-β/Smad Pathway in the Transcription of Pancreas-Specific Genes During Beta Cell Differentiation

Preventing Tumor Progression to the Bone by Induced Tumor-Suppressing MSCs: Erratum

Corrigendum to 'downregulation of ABLIM3 Confers to the Metastasis of Neuroblastoma Via Regulating the Cell Adhesion Molecules Pathway' [comput. Struct. Biotechnol. J., Vol. 23 (2024) 1547-1561].

Publisher Correction: Desumoylase SENP6 maintains osteochondroprogenitor homeostasis by suppressing the p53 pathway

[Corrigendum] Comparison of the biological characteristics of human mesenchymal stem cells derived from exfoliated deciduous teeth, bone marrow, gingival tissue, and umbilical cord

Corrigendum to 'CRISPR/Cas9 system and its applications in nervous system diseases' [Genes & Diseases 11 (2024) 675-686]

The Epigenetic Mechanisms of Nanotopography-Guided Osteogenic Differentiation of Mesenchymal Stem Cells via High-Throughput Transcriptome Sequencing [Corrigendum]

Corrigendum to ’Decellularized disc hydrogels for hBMSC tissue-specific differentiation and tissue regeneration’ [Bioactive Materials 6 (2021) 3541–3556]

Corrigendum to “Lipopolysaccharide-induced podocyte injury is regulated by calcineurin/NFAT and TLR4/MyD88/NF-κB signaling pathways through Angiopoietin-like protein 4” [Genes Dis DOI: 10.1016/j.gendis.2020.07.005]

Erratum: Human Umbilical Cord MSCs as New Cell Sources for Promoting Periodontal Regeneration in Inflammatory Periodontal Defect: Errautm.